What is Cardiol Therapeutics Inc. Class A Common Shares's Market Cap?

Cardiol Therapeutics Inc. Class A Common Shares's Market Cap is $222.6M, based on as-reported figures from SEC (XBRL) filings.

What is Cardiol Therapeutics Inc. Class A Common Shares's Enterprise Value?

Cardiol Therapeutics Inc. Class A Common Shares's Enterprise Value is $207.0M, based on as-reported figures from SEC (XBRL) filings.

What is Cardiol Therapeutics Inc. Class A Common Shares's Net Income (TTM)?

Cardiol Therapeutics Inc. Class A Common Shares's Net Income (TTM) is -$24.7M, based on as-reported figures from SEC (XBRL) filings.

What is Cardiol Therapeutics Inc. Class A Common Shares's Diluted EPS (TTM)?

Cardiol Therapeutics Inc. Class A Common Shares's Diluted EPS (TTM) is -0.25, based on as-reported figures from SEC (XBRL) filings.

Cardiol Therapeutics Inc. Class A Common Shares (CRDL) Financial Statements

Cardiol Therapeutics Inc. Class A Common Shares

SIC 8071 · SERVICES-MEDICAL LABORATORIES

FIGI BBG00M0GNQ75

XNAS · usd

2.22▲ 0.02 (0.91%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.20

Day's Range2.16 – 2.24

52-Week Range0.88 – 2.28

Volume1.2M

Avg Volume1.4M

Share Statistics

Shares Outstanding

Employees18

ExchangeXNAS

Listed2019-01-15

Share count as of December 31, 2025

ViewDetail

Period

Loading Income Statement…

Key questions about Cardiol Therapeutics Inc. Class A Common Shares (CRDL)

What is Cardiol Therapeutics Inc. Class A Common Shares's Market Cap?: Cardiol Therapeutics Inc. Class A Common Shares's Market Cap is $222.6M, based on as-reported figures from SEC (XBRL) filings.
What is Cardiol Therapeutics Inc. Class A Common Shares's Enterprise Value?: Cardiol Therapeutics Inc. Class A Common Shares's Enterprise Value is $207.0M, based on as-reported figures from SEC (XBRL) filings.
What is Cardiol Therapeutics Inc. Class A Common Shares's EV / EBITDA?: Cardiol Therapeutics Inc. Class A Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Cardiol Therapeutics Inc. Class A Common Shares's Net Income (TTM)?: Cardiol Therapeutics Inc. Class A Common Shares's Net Income (TTM) is -$24.7M, based on as-reported figures from SEC (XBRL) filings.
What is Cardiol Therapeutics Inc. Class A Common Shares's EBITDA?: Cardiol Therapeutics Inc. Class A Common Shares's EBITDA is -$25.0M, based on as-reported figures from SEC (XBRL) filings.
What is Cardiol Therapeutics Inc. Class A Common Shares's Diluted EPS (TTM)?: Cardiol Therapeutics Inc. Class A Common Shares's Diluted EPS (TTM) is -0.25, based on as-reported figures from SEC (XBRL) filings.
What is Cardiol Therapeutics Inc. Class A Common Shares's Net Debt?: Cardiol Therapeutics Inc. Class A Common Shares's Net Debt is -$15.6M, based on as-reported figures from SEC (XBRL) filings.